| Financial Year |
March 31 2023 |
| Monetary Funds |
1,174,907,171.63 |
| Held-for-trading Financial Assets |
427,769,014.91 |
| Notes Receivable |
-- |
| Accounts Receivable |
122,013,088.41 |
| Advances to Suppliers |
50,417,078.80 |
| Other Receivables |
2,054,081.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,268,371.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,714,902.60 |
| Total Current Assets |
2,060,036,109.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
301,415,454.12 |
| Under-construction Projects |
18,149,541.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,913,137.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,515,640.74 |
| Other Non-Current Assets |
21,086,103.00 |
| Sub-Total of Non-Current Assets |
361,719,876.20 |
| Total Assets |
2,421,755,986.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,083,296.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,727,561.23 |
| Taxes Payable |
9,556,192.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,997,359.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,316,729.26 |
| Sub-Total of Current Liabilities |
107,420,361.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,428,669.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,268,289.17 |
| Total Liabilities |
133,688,650.32 |
| Paid-In Capital(Or Share Stock) |
357,682,509.00 |
| Capital Surplus |
687,558,005.89 |
| Surplus Reserve |
298,815,816.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
942,112,865.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,288,067,335.79 |
| Owner's Equity（Stockholder's Equity） |
2,288,067,335.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,421,755,986.11 |
